We are live on ! Find out more
IMNP

Immune Pharmaceuticals
IMNP

Delisted

IMNP was delisted on the 25th of July, 2018.

11 hedge funds and large institutions have $227K invested in Immune Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.22% less ownership

Funds ownership: 1.81% → 1.59% (-0.22%)

15% less funds holding

Funds holding: 13 → 11 (-2)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $27.4K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IMNP Hedge Fund Activity: Q2 2016 in Review

11 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Immune Pharmaceuticals (IMNP) for Q2 2016, worth a combined $227K — down 19% from $280K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of IMNP and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was BlackRock Fund Advisors, cutting an estimated $24.2K.

  • 11 institutional investors held Immune Pharmaceuticals (IMNP) as of Q2 2016, down from 13 in Q1 2016.
  • Funds reported $227K of Immune Pharmaceuticals stock for Q2 2016, down 19% quarter-over-quarter.
  • 2 funds opened new Immune Pharmaceuticals positions in Q2 2016 and 3 closed out, a net change of -1 holder.
  • The largest Immune Pharmaceuticals seller in Q2 2016 was BlackRock Fund Advisors, an estimated $24.2K sold.

Based on aggregated 13F filings for Q2 2016.